Princess Margaret Cancer Centre Research’s Post

Cancer has many faces, some of which are only slowly revealing themselves. Work (https://lnkd.in/eRrzpkjd) by Panagiotis Karras, PhD, Ada Nowosad, Jean-Chris Marine, and colleagues at the VIB-KU Leuven Center for Cancer Biology pull back the mask on the role of non-genetic mechanisms and the tumor microenvironment in the development and metastasis of cancer. Want to know even more? Today is the last day to register for VIB's Immuno-Oncology conference!

📣Registration is open for our 2024 Early Detection of Cancer Conference, taking place in San Francisco, from 22-24 October. This year’s event is hosted by the Canary Center at Stanford University in partnership with us and the OHSU Knight Cancer Institute. 2024 session topics include: 🔬How is biology informing early detection? 💻Emerging technologies for cancer early detection 🥼Insights from Early Detection Trials 💡Artificial Intelligence – promises vs. reality for early detection  Secure your place today👉https://bit.ly/44ybzV2

MIT Koch Institute for Integrative Cancer Research spans all stages of the research pipeline—from bench to bedside. Our researchers ask fundamental questions about basic biological processes and invent new technologies to address critical cancer challenges. Part of that research is done by scientists in the Convergence Scholars Program (CSP). These postdocs understand a broad range of disciplinary approaches, are able to ask creative questions, and are trained to answer those questions with diverse tools. In these series of lightning talks, these postdocs will tell you how they are preparing for life beyond the bench with CSP. RSVP: https://bit.ly/4cQ6sly

This episode is a must! #Cancerawarenessmonth

MIT Koch Institute for Integrative Cancer Research spans all stages of the research pipeline—from bench to bedside. Their researchers ask fundamental questions about basic biological processes and invent new technologies to address critical cancer challenges. Part of that research is done by scientists in the Convergence Scholars Program (CSP). These postdocs understand a broad range of disciplinary approaches, are able to ask creative questions, and are trained to answer those questions with diverse tools. In these series of lightning talks, these postdocs will tell you how they are preparing for life beyond the bench with CSP. RSVP: https://bit.ly/4cQ6sly

Hundreds of scientists, clinicians, students and community advocates gathered at the Science Museum of Virginia for Massey's 3rd annual Gordon Ginder Innovations in Cancer Symposium. The conference, moderated by Massey researchers Autumn Lanoye, Ph.D., and Can Senkal, Ph.D., featured a wide range of discussions and presentations on various topics around stress and cancer, including primary care perspectives on the correlation between stress and chronic health conditions like cancer; the molecular effects of various stressors on the genetic makeup of younger cancer patients; effective cognitive behavioral stress management strategies in cancer survivors; among many others. https://lnkd.in/ek8S_4-K

𝗖𝗮𝗻 𝘄𝗲 𝗺𝗮𝗸𝗲 𝗶𝘁 𝘂𝗽 𝘁𝗼 𝟱𝟬%? – 𝗢𝗻𝗹𝘆 3️⃣ 𝗺𝗼𝗿𝗲 𝗱𝗮𝘆𝘀 𝘁𝗼 𝗽𝗮𝗿𝘁𝗶𝗰𝗶𝗽𝗮𝘁𝗲! #RaceTo50 Currently, the third N² Survey is taking place until the 19th of May. It's a joint survey assessing the working conditions of ~16,000 doctoral researchers at the large non-university research institutes – the Helmholtz-Gemeinschaft, Max Planck Society, and Leibniz-Gemeinschaft. 𝗔𝘀 𝘄𝗶𝘁𝗵 𝗮𝗹𝗹 𝘀𝘁𝘂𝗱𝘆 𝗿𝗲𝘀𝘂𝗹𝘁𝘀, 𝗮 𝗵𝗶𝗴𝗵 𝗹𝗲𝘃𝗲𝗹 𝗼𝗳 𝗽𝗮𝗿𝘁𝗶𝗰𝗶𝗽𝗮𝘁𝗶𝗼𝗻 𝗶𝘀 𝗰𝗿𝘂𝗰𝗶𝗮𝗹! To ensure that the obtained results are representative, it is important that as many doctoral students as possible from all areas of #HelmholtzMunich participate in the survey. 𝗪𝗵𝘆 𝗶𝘀 𝘆𝗼𝘂𝗿 𝗽𝗮𝗿𝘁𝗶𝗰𝗶𝗽𝗮𝘁𝗶𝗼𝗻 𝘀𝗼 𝗶𝗺𝗽𝗼𝗿𝘁𝗮𝗻𝘁 𝘁𝗼 𝘂𝘀? Your feedback is invaluable for us as it helps us to understand the current situation of doctoral researchers at Helmholtz Munich. It will enable us to identify areas where we can improve the conditions for our doctoral researchers – for 𝙮𝙤𝙪! ➡ 𝗟𝗶𝗻𝗸 𝘁𝗼 𝘁𝗵𝗲 𝘀𝘂𝗿𝘃𝗲𝘆: https://lnkd.in/dQg_M2TQ ⬅

Did you know that our #VIBGrandChallenges Pointillism 2.0 project is the very first validation project in our portfolio? 💡 It builds on the results of the initial Pointillism project, in which promising potential biomarkers for immunotherapy response were distilled 🔍 These will be validated and expanded in Pointillism 2.0, aiming for true societal impact in the clinic 🙏 Read more in the brand-new blog https://lnkd.in/eRrzpkjd 👈

Even Nature published publications can get retracted - interesting read below.

Congratulations Fiyinfolu Balogun, MD, PhD, Assistant Professor, Memorial Sloan Kettering Cancer Center, on being awarded the 2024 Lustgarten Equity, Accessibility, and Diversity (LEAD) Project grant for his study “Investigating the molecular bases of pancreatic cancer disparities in underserved minority communities and increasing clinical trial recruitment employing linguistic intervention.” 👏The LEAD Project aims to broaden inclusivity by actively recruiting and retaining patients from underrepresented minority groups in pancreatic cancer clinical trials. 💜 #ResearchIsFundamental https://lnkd.in/ev7HcfT3